Connor, Clark & Lunn Investment Management (CC&L)’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $325K | Sell |
|
|||||
|
2025
Q4 | $6.2M | Sell |
|
|||||
|
2025
Q3 | $11.8M | Buy |
|
|||||
|
2025
Q2 | $4.54M | Buy |
|
|||||
|
2025
Q1 | $3.13M | Buy |
|
|||||
|
2024
Q4 | $854K | Buy |
|
|||||
|
2024
Q3 | $804K | Buy |
|
|||||
|
2024
Q2 | $429K | Sell |
|
|||||
|
2024
Q1 | $1.06M | Buy |
|
|||||
|
2023
Q4 | $465K | Sell |
|
|||||
|
2023
Q3 | $541K | Buy |
|